Items where authors include "Griffiths, G."

Article

Willis, T., Siu, Y.L. orcid.org/0000-0003-3585-5861, Taylor, A. et al. (6 more authors) (2024) An integrated climate and water resource climate service prototype for long term water allocation in the Upper Yellow River Region of China. Climate Services, 33. 100445. ISSN 2405-8807

Fennell, D.A. orcid.org/0000-0001-7373-1312, Porter, C., Lester, J. et al. (8 more authors) (2022) Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): a multicentre, randomised, controlled, phase 2 trial. eClinicalMedicine, 52. 101595. ISSN 2589-5370

Fennell, D.A. orcid.org/0000-0001-7373-1312, Porter, C., Lester, J. et al. (14 more authors) (2022) Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. eClinicalMedicine, 48. 101432. ISSN 2589-5370

Fennell, D.A., Griffiths, G., Ottensmeier, C. et al. (4 more authors) (2022) CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? – Authors' reply. The Lancet Oncology, 23 (1). e14-e15. ISSN 1470-2045

Fennell, D.A., Ewings, S., Ottensmeier, C. et al. (36 more authors) (2021) Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. The Lancet Oncology, 22 (11). pp. 1530-1540. ISSN 1470-2045

Crabb, S.J., Danson, S. orcid.org/0000-0002-3593-2890, Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (16 more authors) (2021) Phase I trial of DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine for solid malignancies including urothelial carcinoma (SPIRE). Clinical Cancer Research, 27 (7). pp. 1882-1892. ISSN 1078-0432

Prout, H.C. orcid.org/0000-0003-0170-7027, Barham, A., Bongard, E. et al. (15 more authors) (2018) Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials, 19. 419.

Fennell, D.A., Kirkpatrick, E., Cozens, K. et al. (13 more authors) (2018) CONFIRM: a double-blind, placebo controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial. TRIALS, 19. 233. ISSN 1745-6215

Crabb, S., Danson, S.J., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (12 more authors) (2018) SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial. Trials, 19. 216. ISSN 1745-6215

Neal, R.D., Barham, A., Bongard, E. et al. (15 more authors) (2017) Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. British Journal of Cancer, 116. pp. 293-302. ISSN 0007-0920

Macbeth, F., Noble, S., Evans, J. et al. (13 more authors) (2016) Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial. Journal of Clinical Oncology, 34 (5). pp. 488-494. ISSN 0732-183X

Maddocks, M., Halliday, V. orcid.org/0000-0003-2458-5253, Chauhan, A. et al. (6 more authors) (2013) Neuromuscular Electrical Stimulation of the Quadriceps in Patients with Non-Small Cell Lung Cancer Receiving Palliative Chemotherapy: A Randomized Phase II Study. PLoS ONE, 8 (12). e86059. ISSN 1932-6203

Proceedings Paper

Hanna, G., Griffiths, G., Kirkpatrick, E.V. et al. (11 more authors) (2018) CONFIRM: a phase III randomised trial to evaluate the efficacy of nivolumab versus placebo in relapsed mesothelioma. In: Lung Cancer. 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin. Elsevier , S84-S84.